GMO U.S. Value ETF $GMOV Stock: StoneX Group Inc. Decreases Holdings

Posted by Grant Hamersma on Nov 9th, 2026

StoneX Group Inc. cut its stake in GMO U.S. Value ETF (NYSEARCA:GMOV – Free Report) by 40.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,988 shares of the company’s stock after selling 49,161 shares during the period. StoneX Group Inc. owned 2.43% of GMO U.S. Value ETF worth $2,315,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Essential Partners LLC raised its stake in GMO U.S. Value ETF by 8.6% during the 1st quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock valued at $1,692,000 after acquiring an additional 4,774 shares in the last quarter. Pathway Financial Advisors LLC acquired a new position in GMO U.S. Value ETF during the 2nd quarter worth $246,000. Finally, Fifth Third Bancorp bought a new position in shares of GMO U.S. Value ETF in the first quarter worth $84,000.

GMO U.S. Value ETF Stock Performance

GMO U.S. Value ETF stock opened at $32.70 on Monday. GMO U.S. Value ETF has a 52 week low of $25.92 and a 52 week high of $34.16. The stock has a market cap of $98.10 million, a price-to-earnings ratio of 12.08 and a beta of 0.61. The company’s 50-day moving average price is $32.58 and its two-hundred day moving average price is $30.52.

GMO U.S. Value ETF Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Wednesday, September 30th were paid a dividend of $0.1678 per share. This is a boost from GMO U.S. Value ETF’s previous quarterly dividend of $0.1283. This represents a $0.67 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Wednesday, September 30th.

GMO U.S. Value ETF Profile

(Free Report)

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.